Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.

Vanita Noronha, Kumar Prabhash, Vijay Patil et al.|Journal of Clinical Oncology|2017

Cited by 26